| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 05/19/2005 | US20050107435 antibiotics such as (5S,5S')-N-(3-{4'-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2,2'-difluoro-biphenyl-4-yl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide, used for treating a bacterial infections in mammals |
| 05/19/2005 | US20050107396 for the treatment of psychotic disorders and Parkinson's disease; crystalline polymorph |
| 05/19/2005 | US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
| 05/19/2005 | US20050107383 such as 2-(2-propenylthio)-4-(4-trifluoromethylphenyl)benzonitrile; for farm and garden pests including mites, lepidopterans, hemipterans, hymenopterans, orthopterans and isopterans; antiviral agent, fungicide, herbicide |
| 05/19/2005 | CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents |
| 05/18/2005 | CN1617850A Dibenzylamine compound and medicinal use thereof |
| 05/18/2005 | CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity |
| 05/18/2005 | CN1617704A Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/17/2005 | US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
| 05/12/2005 | WO2004072087A3 Metal complexes as light-absorbing compounds in the information layer of optical data carriers |
| 05/12/2005 | US20050101798 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/12/2005 | US20050101784 Chlorinating a 2-alkyl-6-aminobenzoxazole in an ethyl acetate solvent to form a 2-alkyl-6-amino-7-chlorobenzoxazole in which the 2-alkyl group is unbranched at the alpha carbon, for preparing a 6-chloro-2,5-dicarbonamido phenol compound |
| 05/12/2005 | US20050101647 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma |
| 05/12/2005 | US20050101643 Amino acids with affinity for the alpha2delta-protein |
| 05/12/2005 | US20050101637 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/12/2005 | US20050101636 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 05/12/2005 | US20050101590 Cannabinoid receptor agonists |
| 05/12/2005 | CA2539335A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| 05/12/2005 | CA2535036A1 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/11/2005 | EP1529778A1 Production method of pyrimidine derivative, intermediate therefor |
| 05/11/2005 | EP1529777A2 Process and oxazolidine intermediate for the synthesis of taxanes |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | CN1615299A Xanthine oxidase inhibitors |
| 05/11/2005 | CN1615284A Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/06/2005 | WO2005040355A2 Tao kinase modulators and methods of use |
| 05/06/2005 | WO2005040161A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 05/06/2005 | WO2005040139A2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 05/06/2005 | WO2005040138A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | WO2005040129A2 Ccr3 receptor antagonists |
| 05/06/2005 | WO2005040127A1 Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same |
| 05/06/2005 | WO2005040121A2 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/06/2005 | WO2005040109A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 05/06/2005 | WO2005039570A1 TGF-β INFORMATION TRANSFER PATHWAY INHIBITOR |
| 05/06/2005 | WO2004089880A3 Carbamates useful as fragances |
| 05/06/2005 | CA2543555A1 Therapeutic agent for keratoconjunctival disorder |
| 05/06/2005 | CA2543419A1 Ccr3 receptor antagonists |
| 05/06/2005 | CA2542695A1 Substituted benzylaminoalkylene heterocycles |
| 05/06/2005 | CA2542064A1 Tao kinase modulators and methods of use |
| 05/06/2005 | CA2539967A1 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/05/2005 | US20050096471 Process for producing biaryl compound |
| 05/05/2005 | US20050096366 thiazolidin-2,4-diones or -oxazolidin-2,4-diones; obesity, inflammation, autoimmune diseases (multiple sclerosis and rheumatoid arthritis); increase the leptin level; no liver toxicity; inhibits TNF- alpha , IL-1, IL-6, IL-1 beta and cyclooxygenase COX-2; no affinity for PPAR-g; non-adipogenic. |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050095652 Solid support comprising immobilized biopolymers for use as assay in monitoring receptor ligand interaction; drug screening; antibodiy sensitivity |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1611494A Method for chemical synthesis of N-[1 (1)-carbethoxy-3-hydro cinnamyl]-L-ulamine -N- carboxylic anhydride |
| 05/03/2005 | US6887995 Reacting N-aryl-O-alkylcarbamate with an amide derivative in the presence of a lithium cation, a base, and a nucleophile |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 05/03/2005 | US6887871 Use of phenylheteroakylamine derivatives |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 04/28/2005 | WO2005037829A1 1,3-benzoxazolyl derivatives as kinase-inhibitors |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2004083170A3 Compounds, a process for their preparation and their use as dyes and pigments |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | US20050090534 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 04/28/2005 | US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | CA2539767A1 1,3-benzoxazolyl derivatives as kinase inhibitors |
| 04/27/2005 | EP1525192A2 Co-surfactants based on aldehydes |
| 04/27/2005 | EP1524977A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/27/2005 | EP1011651B1 Method of treating diabetes and related disease states |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610659A Carboxylic acid derivative |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | US6884891 Methine dyes, manufacturing methods thereof, and silver halide photographic materials containing same dyes |
| 04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
| 04/26/2005 | US6884812 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035530A1 A novel crystalline form of linezolid |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005016866A3 Process for producing optically actiive beta-amino acid derivatives |
| 04/21/2005 | WO2005016267A3 Oxazole compounds for the treatment of neurodegenerative disorders |
| 04/21/2005 | WO2004062601A3 Antibacterial agents |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085523 Imidazolyl and pyrazolyl ethyne compounds |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 04/21/2005 | CA2541086A1 Process for making amide acetals |
| 04/20/2005 | EP1524267A1 Substituted benzylaminoalkylene heterocycles |
| 04/20/2005 | EP1349843B1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 04/20/2005 | EP1317460A4 Compounds containing oxazolidinone moiety and uses thereof |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | CN1608056A Carboxylic acid derivative compounds and agents comprising the compounds as active ingredient |
| 04/20/2005 | CN1608050A Piperazine derivative |
| 04/20/2005 | CN1197851C Method for producing chlorobenzoxazolene |
| 04/14/2005 | WO2005033106A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors |
| 04/14/2005 | WO2005033087A1 Heterocycle-substituted phenylacetylene compound and organic electroluminescent device |
| 04/14/2005 | WO2005002514A3 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |